Related Experiment Video

Updated: Jul 19, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

[Chronic pulmonary thromboembolism revealing beta-thalassemia intermedia after splenectomy]

B Pierre1, F Maillot, D Casset-Sedon

  • 1Service de cardiologie B et CNRS UMR 6542, hôpital Trousseau, 37044 Tours cedex 01, France. pierre_b@med.univ-tours.fr

La Revue De Medecine Interne
|October 24, 2006
PubMed
Abstract

Insights

Beta-thalassemia intermedia patients face variable complications, with increased thromboembolism risk post-splenectomy. This case highlights pulmonary thromboembolism as a potential indicator of beta-thalassemia intermedia.

Area of Science:

  • Hematology
  • Pulmonology
  • Hepatology

Background:

  • Beta-thalassemia intermedia presents with variable clinical manifestations and increased complication rates compared to beta-thalassemia minor.
  • Splenectomy in beta-thalassemia intermedia patients is associated with a heightened risk of thromboembolic events.
  • Complications such as chronic pulmonary thromboembolism and liver iron overload are significant concerns.

Observation:

  • A case study of a beta-thalassemia intermedia patient with moderate chronic hemolytic anemia.
  • The patient presented with chronic pulmonary thromboembolism and significant liver iron overload.
  • A history of splenectomy was noted, potentially contributing to the observed complications.

Findings:

  • The patient's respiratory condition improved with bosentan therapy.
  • Bosentan treatment did not exacerbate the existing hepatopathy.
  • Thromboembolic complications may serve as an indicator for beta-thalassemia.

Implications:

  • This case underscores the potential for thromboembolism to signal underlying beta-thalassemia.
  • It prompts a re-evaluation of the risk-benefit ratio of splenectomy in managing beta-thalassemia intermedia.
  • Further research is warranted to elucidate the complex interplay between splenectomy, thromboembolism, and beta-thalassemia intermedia.

More Related Videos

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet09:22

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet

Published on: November 4, 2015

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.